Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-808-1 | CAS number: 12034-57-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-08-31 to 2009-10-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Diniobium pentaoxide
- EC Number:
- 215-213-6
- EC Name:
- Diniobium pentaoxide
- Cas Number:
- 1313-96-8
- Molecular formula:
- Nb2O5
- IUPAC Name:
- diniobium pentaoxide
Constituent 1
- Specific details on test material used for the study:
- - Name: Diniobium Pentaoxide
- CAS: 1313-96-8
- Batch No.: AD/4199
- Density: ca. 4.5 g/cm³
- Active components: >98.5%
- Colour: pale yellow
- Physical state: solid
- Storage: at room temperature
- Stability: stable
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, D-33178 Borchen, Germany
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: The animals were derived from a controlled full-barrier maintained breeding system (SPF).
- Age at study initiation: 8 - 9 weeks
- Weight at study initiation:
- Housing: The animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding (lot no. 04.05.09, main test; lot no. 050109, preliminary test)
- Diet (e.g. ad libitum): Free access to Altromin 1324 maintenance diet for rats and mice (lot no.0654)
- Water (e.g. ad libitum): Free access to tap water, sulphur acidified to a pH value of approx. 2.8 (drinking water, municipal residue control, microbiol. controlled at regular intervals)
- Acclimation period: at least 5 days
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): at least I 0 x I hour
- Photoperiod (hrs dark / hrs light): 12 / 12
- IN-LIFE DATES: From: 2009-09-14 To: 2009-10-01
Study design: in vivo (LLNA)
- Vehicle:
- other: acetone olive oil (AOO 3+1(v/v)
- Concentration:
- 12.5%, 25% and 50% (suspended in AOO 3+1)
- No. of animals per dose:
- 3 (2+1 control) animals for the pretest
5 animals/ test group in the main study - Details on study design:
- PRE-SCREEN TESTS:
To determine the highest tolerated and non-irritant test concentration a preliminary test was performed. For this purpose, two animals were treated by topical application with the test item on three consecutive days at a concentration of 50% (suspended in AOO) to the entire dorsal surface of each ear. One further animal was treated with 100% AOO and served as negative control.
From day 1 to day 4 the ear thickness of each animal was measured. During this period also all clinical signs were recorded. Cageside observations included spontaneous activity, lethargy, recumbent position, convulsions, tremors, apnoea, asphyxia, vocalisation, diarrhoea, changes in the skin and fur, eyes and mucous membranes (salivation, discharge).
For details on results please refer to the results section "Any other information on results incl. tables ".
MAIN STUDY
- Topical Application
Each mouse was treated by topical application of 25 μL of the selected solution to the entire dorsal surface of each ear. Topical applications were performed once daily over three consecutive days.
- Administration of 3H-methyl thymidine
Five days after the first topical application all mice were dosed with 20 μCi 3H-methyl thymidine by intravenous injection (tail vein) of 250μL of 3H-methyl thymidine, diluted to a working concentration of 80μCi/mL.
- Preparation of cell suspension
Approximately 5 hours after 3H-methyl thymidine-injection all mice were sacrificed by cervical dislocation. The draining “auricular lymph nodes” were excised, individually pooled for each animal (2 lymph nodes per animal) and collected in phosphate buffered saline (PBS). A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through polyamide gauze (200 mesh size). After washing the gauze with PBS the cell suspension was pelleted in a centrifuge. The supernatant was discarded and the pellets were resuspended with PBS. This washing procedure was repeated.
After the final wash each pellet was resuspended in approx. 1 mL 5% TCA at approx. 4 °C for approximately 18 hours for precipitation of macromolecules. Each precipitate was once washed again, resuspended in 1 mL 5% TCA and 7 mL scintillation fluid was added. Then this solution was transferred into scintillation vials and stored at room temperature overnight.
- Determination of incorporated 3H-methyl thymidine
The 3H-methyl thymidine – incorporation was measured in a ß-counter and expressed as the number of disintegrations per minute (DPM). Similarly, background 3H-methyl thymidine levels were also measured (5% TCA). Determination of radioactivity was performed individually for each animal.
OTHER:
Reliability checks with a positive control substance was performed periodically in the performing laboratory. - Positive control substance(s):
- other: P-Phenylenediamine (CAS 106-50-3)
Results and discussion
- Positive control results:
- Reliability checks with a positive control substance was performed periodically in the performing laboratory. The mean SI-value of the latest reliability check was 13.8 (see table 2 in box "Any other information on results incl. tables).
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 0.7
- Variability:
- SD = 0.3
- Test group / Remarks:
- 12% Diniobium pentaoxide
- Parameter:
- SI
- Value:
- 1.3
- Variability:
- SD = 0.4
- Test group / Remarks:
- 25 % Diniobium pentaoxide
- Parameter:
- SI
- Value:
- 0.9
- Variability:
- SD = 0.4
- Test group / Remarks:
- 50 % Diniobium pentaoxide
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
For detailed results please refer to table 3 presented in box "Any other information on results incl. tables".
EC3 CALCULATION
The EC3 value (derived by linear interpolation) could not be calculated as the stimulation indices of all concentrations were below 3.
CLINICAL OBSERVATIONS:
All animals survived throughout the test period without showing any clinical signs.
BODY WEIGHTS
All animals showed the expected weight development, which includes a weight loss of up to 2 g throughout the study.
Any other information on results incl. tables
Results of the preliminary test:
Table 1: Ear Thickness - Preliminary test
Group | Animal No. | Day 1 [mm] | Day 2 [mm] | Day 3 [mm] | Day 4 [mm] |
50% Diniobium Pentaoxide | 1 | 0.18 | 0.17 | 0.17 | 0.18 |
2 | 0.17 | 0.17 | 0.17 | 0.18 | |
100 % AOO (3+1) Negative control |
3 | 0.17 | 0.17 | 0.18 | 0.17 |
Neither signs of systemic toxicity nor signs of irritation at the application site could be detected in the animals.
Results of the Reliability Check (Positive Control)
Table 2: Stimulation indices of the Positive-Control Group of the Recent Study
Test Item | Concentration [%] |
Animal Number | Stimulation Index |
AOO (3+ I (v/v) Acetone/Olive Oil) | 100 | 16 | |
17 | |||
18 | |||
19 | |||
20 | |||
MV | 1.0 | ||
SD | |||
Phenylenediamine | 1 | 81 | 10.2 |
82 | 11.0 | ||
83 | 14.0 | ||
84 | 17.1 | ||
85 | 16.8 | ||
MV | 13.8 | ||
SD | 2.9 |
Results of the Main Study
Table 3: Stimulation Indices obtained in the main study
Test Item | Concentration [%] |
Animal Number | Stimulation Index |
AOO (3+ I (v/v) Acetone/Olive Oil) | 100 | 16 | |
17 | |||
18 | |||
19 | |||
20 | |||
MV | 1.0 | ||
SD | |||
Diniobium Pentaoxide | 12.5 | 1 | 1.0 |
2 | 1.0 | ||
3 | 0.4 | ||
4 | n.d.* | ||
5 | 0.5 | ||
MV | 0.7 | ||
SD | 0.3 | ||
Diniobium Pentaoxide | 25 | 6 | 1.0 |
7 | 1.0 | ||
8 | 1.7 | ||
9 | 0.7 | ||
10 | 1.8 | ||
MV | 1.3 | ||
SD | 0.4 | ||
Diniobium Pentaoxide | 50 | 11 | 0.3 |
12 | 0.9 | ||
13 | 1.3 | ||
14 | 1.0 | ||
15 | n.d.* | ||
MV | 0.9 | ||
SD | 0.4 |
* = outlier, failed Grubbs, Nalimov and Dixon; n.d. = not determined
If not noted individually, the results include both lymph nodes of an animal.
SD = standard deviation; MV = mean value
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Diniobium pentaoxide is not sensitizing under the conditions of this LLNA study (OECD 429).
- Executive summary:
In a dermal sensitization study conducted according to OECD 429 with Diniobium pentaoxide (> 98.5 % purity) suspended in AOO (3 +1 v/v acetone/olive oil), young adult female CBA/OlaHsd mice (5 per dose group) were tested at concentrations of 12.5% (w/v), 25 % (w/v) and 50 % (w/v) in a local lymph node assay (LLNA). Due to animal welfare reasons a periodically performed positive control (Phenylenediamine in AOO (3 +1 v/v) was used. There was no mortality nor clinical observations nor effects on body weights observed. None of the tested concentrations of the test substance reached the stimulation index threshold of 3. Therefore no EC3 value could be determined. In this study, Diniobium pentaoxide is not a dermal sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.